David Weingeist

Company: Johnson & Johnson Innovative Medicines

Job title: Scientific Director

Seminars:

Transforming Clinical Trials with Urine Assay Technology: A Promising Solution 10:00 am

 Detection in urine provides a non-invasive screening approach and mitigates certain challenges with tissue testing Early detection with urine-based assays in bladder cancer can lead to earlier treatment, better patient outcomes, and potentially a higher chance of cure Tumor markers in urine can also be utilized for disease monitoring and longitudinal response to treatment Urine…Read more

day: Day Two